Eli Lilly (NYSE:LLY) is acquiring Imclone (NYSE:IMCL), the maker of head and neck cancer treatment drug Erbitux, for $6.5 billion or $70 a share the company announced on October 6. Imclone stock has managed to recover from an insider trading scandal in 2001, rejection from the FDA for its Erbitux product in the same year, and a corporate raid from billionaire investor Carl Icahn in 2006.

Imclone is a company dedicated to the field of oncology that investors should get to know even as it is undergoing its own transformation.

Lilly's Stable
Eli Lilly brings to the table its lineup of drugs including schizophrenia drug Zyprexa, its depression drug Cymbalta and its cancer fighter Gemzar. Lilly's top three selling drugs previously mentioned made up 45% of its $9.9 billion in revenue for the first half of 2008. Lilly, in conjunction with ICOS Corporation, is also the maker of erectile dysfunction drug Cialis, one of the company's fastest growing drugs in terms of sales from the previous year.

Imclone Second Quarter 2008
Imclone was able to increase revenue 12.75% for the first half of the year to $329 million over the same period a year ago. Merck (NYSE:MRK) and Bristol-Myers Squibb (NYSE:BMY) are the primary contributors to Imclone's revenue from royalties, licensing and milestone fees from the worldwide sales of Erbitux. While the numbers appear promising, Imclone revenue could not exceed the pace of its expenses. Higher costs related to a patent dispute with Abbott Labs (NYSE:ABT), SG&A and R&D sent expenses up 27.66% which caused operating income to drop 21.71% to $69 million. Despite the growth of expenses investors have rewarded Imclone by pushing its stock price up 51.49% this year.

Environment
Many individuals know, whether it's through personal experience or by way of friends and family, the devastating effects cancer can have on a loved one. Although forecasts by the American Cancer Society calculate the estimate for new cancer cases to rise from 12 million in 2007 to 27 million by 2050, preventative measures including regular doctor visits, limiting the use of tobacco products, regular exercise and healthy dietary choices can have a positive impact and reverse the trend.

Final Thoughts
On the day of the announcement Eli Lilly's stock traded down more than 7% intraday on news of the premium it will be paying to acquire Imclone. This continued Eli Lilly's downward trajectory over the past year. Although the Imclone will be a part of the much larger Lilly, the new combination of drugs treatments available benefits investors by diversifying marketable products of the underlying investment. Investors should consider a dollar cost averaging approach to buy into Lilly as a way to stay close to Imclone.

For more on this strategy, read Dollar-Cost Averaging Pays.

Related Articles
  1. Investing News

    Bank Stocks: Time to Buy or Avoid? (WFC, JPM, C)

    Bank stocks have been pounded. Is this the right time to buy or should they be avoided?
  2. Stock Analysis

    Why the Bullish Are Turning Bearish

    Banks are reducing their targets for the S&P 500 for 2016. Here's why.
  3. Stock Analysis

    How to Find Quality Stocks Amid the Wreckage

    Finding companies with good earnings and hitting on all cylinders in this environment, although possible, is not easy.
  4. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  5. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  6. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  7. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  8. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  9. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  10. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center